DLL4 and neoplasm: Using RBPj-Notch reporter activation as an indicator for Notch activation and combining with specific Notch receptor antagonists, it was found that this effect proceeded from endothelial Dll4 signaling through Notch1, but not Notch3, in neighboring tumor cells [135].